Tag: Clinical Development
-
Clinical Development: Phases I to III
This is Part 5 in The Drug Development Playbook. In this article we move into clinical trials from phase I to III.
-
How Genomics Is Changing Drug Target Selection in Big Pharma
The integration of human genetics in pharmaceutical research significantly enhances drug development. By prioritizing targets with genetic support, companies can improve trial efficacy and reduce risks. Utilizing genomics allows for better indication selection, safety predictions, and asset valuation. This strategic approach fosters innovation while addressing ethical considerations in clinical trials.
Aryan Kenia 